Plain-English translation of NCT07449702 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This is a follow-up study for people who already completed an earlier trial testing , a new treatment for moderate-to-severe plaque psoriasis. The study will watch how safe this medication is and how well it works over about 2 years of treatment. You'll receive the medication on different schedules depending on which group you join—some people get it once a year, others twice a year, and some receive no medication initially.
Researchers want to understand whether this medication is safe to use long-term and whether it keeps working over time. This information is important because plaque psoriasis is a chronic condition, and doctors need to know if this treatment can provide lasting relief without causing problems.
You likely qualify if…
You likely don't qualify if…
You'll visit the study clinic regularly over about 2 years (96 weeks) to receive the medication and have your skin checked. Depending on which treatment group you're assigned to, you'll receive injections or infusions either once or twice per year, or you may start with no medication and receive it once your skin improves enough. After your final treatment visit, you'll have follow-up appointments for about a year to make sure everything continues to go well.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States